NASI Products Sample Clauses

NASI Products. All regulatory matters regarding the NASI Products shall remain under the control of NASI, subject to the participation by NOMOS in matters related to the marketing of the NASI Products to Cancer Treatment Specialists in the Territory. Notwithstanding the foregoing, NASI shall promptly provide NOMOS with copies of all communications received from any regulatory agency or authority concerning the NASI Products or any Marketing Materials related to the NASI Products.
Sample 1
AutoNDA by SimpleDocs
NASI Products. NASI shall furnish NOMOS with efficacy and safety information reasonably requested by NOMOS to assist NOMOS in promoting the NASI Products to Cancer Treatment Specialists in the Territory, including without limitation relevant clinical and safety data included and additional information, if any, related to the efficacy and safety profile of the NASI Products. Except for information to be disclosed to Cancer Treatment Specialists in connection with conducting Details, such information shall be treated as Confidential and Proprietary Information pursuant to Section 10 of this Agreement and shall not be disclosed to third parties without NASI's prior written approval or direction.
Sample 1
NASI Products. NASI shall have the sole authority and responsibility to respond to any regulatory agencies with respect to NASI Product Technical Complaints and medical complaints and to handle all returns, recalls or market withdrawals of the NASI Products in accordance with applicable law, at NASI's cost and expense.
Sample 1
NASI Products. Upon the termination or expiration of this Agreement for any reason with respect to the NASI Products, NOMOS shall immediately cease all of its promotional and marketing activities for the terminated NASI Products, discontinue any use of the NASI Trademarks related to the terminated NASI Products, and return to NASI or destroy all sales training and Marketing Materials for the terminated NASI Products containing NASI Trademarks. After any such termination, NASI shall retain the right to use any sales training and Marketing Materials developed under the auspices of the PMC during the Term of this Agreement; provided, however, that NASI shall have no further right to use NOMOS' name or any of the NOMOS Trademarks or logos in connection therewith.
Sample 1
NASI Products. Upon the termination or expiration of this Agreement for any reason with respect to the NASI Products, NOMOS shall immediately cease all of its activities for the terminated NASI Products, discontinue any use of the NASI Trademarks related to the terminated NASI Products, and return to NASI or destroy all materials containing NASI Trademarks.
Sample 1

Related to NASI Products

  • Licensed Products Lessee will obtain no title to Licensed Products which will at all times remain the property of the owner of the Licensed Products. A license from the owner may be required and it is Lessee's responsibility to obtain any required license before the use of the Licensed Products. Lessee agrees to treat the Licensed Products as confidential information of the owner, to observe all copyright restrictions, and not to reproduce or sell the Licensed Products.

  • New Products You agree to comply with NASD Notice to Members 5-26 recommending best practices for reviewing new products.

  • Competing Products The provisions of Section 21 are set forth on attached Exhibit H and are incorporated in this Section 21 by this reference.

  • Products 1.1. The information (including but not limited to the quantity, rated hashrate, unit price (“Unit Price”), total price for one item (“Total Price (One Item)”), total price for all the items (“Total Purchase Price”) of Products to be purchased by Party B from Party A is as follows (“Products”):

  • Product The term “

  • Licensed Product “Licensed Product” shall mean any article, composition, apparatus, substance, chemical material, method, process or service whose manufacture, use, or sale is covered or claimed by a Valid Claim within the Patent Rights. For clarity, a “Licensed Product” shall not include other product or material that (a) is used in combination with Licensed Product, and (b) does not constitute an article, composition, apparatus, substance, chemical material, method, process or service whose manufacture, use, or sale is covered or claimed by a Valid Claim within the Patent Rights.

  • Manufacture of Products All Products marketed through Grantor's Web ------------------------- Site shall be manufactured, packaged, prepared, and shipped in accordance with the specifications and requirements described on Exhibit A hereto as it may be modified from time to time. Quality control standards relating to the Product's weight, color, consistency, micro-biological content, labeling and packaging are also set forth on Exhibit A. In the event that Exhibit A is incomplete, Products shall be manufactured and shipped in accordance with industry standards.

  • Manufacture (a) Manufacturer shall only manufacture the specific number of Products as requested by Company and at no time shall manufacture excess goods or overruns. Manufacturer shall not sell any Products bearing the Trademarks to any third parties without the express written consent of Company.

  • Other Products After clinical or other evidence, provided in writing [***] to Company, demonstrating the practicality of a particular market or use within the LICENSED FIELD which is not being developed or commercialized by Company, Company shall either provide JHU with a reasonable development plan and start development or attempt to reasonably sublicense the particular market or use to a third party. If within six (6) months of such notification [***] Company has not initiated such development efforts or sublicensed that particular market or use, JHU may terminate this license for such particular market or use. This Paragraph shall not be applicable if Company reasonably demonstrates to JHU that commercializing such LICENSED PRODUCT(S) or LICENSED SERVICE(S) or granting such a sublicense in said market or use would have a potentially adverse commercial effect upon marketing or sales of the LICENSED PRODUCT(S) developed and being sold by Company.

  • Company Products Schedule 2.10(d) of the Company Disclosure Letter lists all Company Products, and for each such product or feature (and each version thereof) identifying its release date.

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!